The Mirken Family Clinical Neuroscience Institute uses a multidisciplinary team to coordinate and unite the clinical neuroscience activities across the entire Mount Sinai Health System to foster clinical and translational research partnerships.
One of our first research projects explores treating patients with Parkinson's disease, dystonia, and psychiatric illnesses with deep brain stimulation. We will also focus on investigating, among other topics, the genetic risk factors that contribute to the development and progression of neurological diseases. As part of this research, Institute scientists will work to identify biomarkers and potential treatment targets.
Our research team includes physicians and scientists from throughout the Mount Sinai Health System specializing in neurology, neurosurgery, neuroimaging, neurophysiology, and neurogenetics. The institute was established in 2013 through a generous gift from Mount Sinai Health System Trustee Emeritus Alan Mirken.
